Applied Genetic Technologies Corp. (AGTC:NASDAQ)
Applied Genetic Technologies Corp. (AGTC:NASDAQ) has a $310M market cap. Making its second appearance on the Small-Cap Biotech Watchlist, AGTC is a gene therapy company focused on ophthalmology, with two programs in clinical development.
Shares of Applied Genetics Technologies Corp. endured their greatest ever one-day selloff Tuesday, after a disillusioning upgrade of a clinical trial incited an investigator to swing to a bearish position from a bullish one.
The biotechnology organization said late Monday that patient enlistment for an early-arrange trial for its treatment of retinoshisis- – the detachment of the retina into two layers-